NCT05052606 Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry
| NCT ID | NCT05052606 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Turner Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2020-05-20 |
| Primary Completion | 2025-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2020-05-20 with a primary completion date of 2025-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
INSIGHTS is a registry research study that collects key information on medical history for girls and women with Turner syndrome and the clinical care they receive. This includes genetic tests, imaging, medications, and more for hundreds of patients seen at a number of clinics across the US. In addition to learning a lot about the current state of health for individuals with TS, INSIGHTS serves as an infrastructure to conduct future studies are meaningful to patients and their families.
Eligibility Criteria
Inclusion Criteria: 1. Individuals with TS and TS variants as defined by the TS Clinical Practice Guideline definition (karyotype consistent with TS, phenotypic female, clinical feature(s) of TS) 2. Informed consent/assent as appropriate Exclusion Criteria: a. Lack of a TS diagnosis on file
Contact & Investigator
Shanlee M Davis, MD, PhD
PRINCIPAL INVESTIGATOR
Children's Hospital Colorado
Frequently Asked Questions
Who can join the NCT05052606 clinical trial?
This trial is open to female participants only, studying Turner Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05052606 currently recruiting?
Yes, NCT05052606 is actively recruiting participants. Contact the research team at shanlee.davis@childrenscolorado.org for enrollment information.
Where is the NCT05052606 trial being conducted?
This trial is being conducted at Aurora, United States, Washington D.C., United States, Glenview, United States, Lawrence, United States and 6 additional locations.
Who is sponsoring the NCT05052606 clinical trial?
NCT05052606 is sponsored by University of Colorado, Denver. The principal investigator is Shanlee M Davis, MD, PhD at Children's Hospital Colorado. The trial plans to enroll 5,000 participants.